No golden signals (RSI<30 + insider buying) anywhere in the 59-stock universe. Three net buyers: TSLA (+$205.3M), CRSP (+$28.1M), ASAN (+$8.5M). Three names with insider selling into near-oversold territory: NFLX (RSI 31.9, -$1.4B), GOOGL (RSI 34.0, -$289.3M), AKAM (RSI 30.8, -$20.1M) — per precomputed summaries, NONE are technically below RSI 30 despite the scratch report showing 27-28. The mega-distribution list is dominated by AMZN (-$9.2B, approaching SMA200), LLY (-$3.5B into strength), NVDA (-$3.3B), PLTR (-$2.5B).

Data discipline: RSI and prices from precomputed summaries (insider-universe.json) as authoritative source. Insider flow signals (buy/sell dollar amounts) from the pre-run insider report. The insider report's own RSI calculation showed 27-28↓ for NFLX/GOOGL/AKAM; precomputed summaries show 30.8-34.0 for those same names — use precomputed values. All near-oversold designations below use the summary RSI.

• NO GOLDEN SIGNALS FOR 2ND CONSECUTIVE WEEK. Zero stocks in the 59-name universe show RSI<30 + net insider buying. The market has not handed insiders a true capitulation buy opportunity yet. This is a bearish absence — smart money isn't piling in at the lows because the lows aren't confirmed.
• CRSP: CLEANEST BUY SIGNAL. RSI 57.4, weak-up trend, +$28.1M insider buy, only -30% from high, +2.6% 30d with positive momentum. Biotech capital cycle thesis relevant. Best risk/reward buy in this batch given the healthy structure.
• TSLA: BIG DOLLARS, BAD STRUCTURE. +$205.3M is the largest insider buy in the universe. But RSI 41.4 and death-cross trend mean this is NOT a trend-hold entry — the trend hasn't bottomed → popped → flagged yet. Monitor for structure improvement. Don't buy the first insider print without confirmed reversal.
• NFLX/AKAM/GOOGL: SELLING INTO WEAKNESS. Precomputed RSI: NFLX 31.9, AKAM 30.8, GOOGL 34.0 — all near-oversold but NOT below 30. The insider selling INTO this multi-week selloff is the bearish signal. When insiders flee approaching-oversold names, there is no floor established.
• AMZN -$9.2B IS THE BIGGEST FLAG IN THE SCAN. This single number dwarfs everything else. AMZN at $232.69 is within $0.10 of its SMA200 ($232.77 approx) — death cross is literally days away. Insiders appear to be front-running it. Watch for AMZN death-cross confirmation.
• PANW -$1.7B INTO ATH: THIS IS NOT NECESSARILY BEARISH. PANW RSI 70.5, +22.43% 30d — insiders are trimming genuine 22% monthly gains. This is normal. Different from SNOW (death cross) where $1.4B of selling accompanied a +42% 30d move without underlying structural support.

• AMZN -$9.2B insider distribution is the single largest insider sell signal in the entire universe — and the stock sits at its SMA200. Death-cross watch is open.
• NFLX -15.5% 30d to $73.81 with -$1.4B insider selling is a capitulation sell, not a capitulation buy.
• PLTR -13.59% 7d, -14.78% 30d — collapse regime with -$2.5B insider selling; death cross confirmed; -45.58% from its 52wk high.
• PANW continued its +22.43% 30d run to RSI 70.5 / only -0.67% from ATH — insiders trimming into genuine strength is the most rational action here.
• TSLA -8.46% 7d to $379.71 — the +$205.3M buy into weakness is notable; death-cross structure means it's too early to act per trend-hold rules, but worth a watch tab.
• CRSP +5.6% 7d with +$28.1M buy — the only name with healthy trend + insider buying. Biotech capital cycle thesis aligns.

• Does AMZN cross its SMA200 next week? If so, does the -$9.2B insider distribution mark a weeks-long top or a short-term distribution event?
• Is CRSP's +$28.1M insider buy the start of a sustained accumulation phase, or is it isolated?